`
`
`
`Paper No. ___
`Date Filed: Jan. 4, 2017
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`AMERIGEN PHARMACEUTICALS LIMITED
`Petitioner,
`
`v.
`
`JANSSEN ONCOLOGY, INC.,
`Patent Owner.
`
`________________
`
`Case IPR2016-002861
`Patent 8,822,438 B2
`
`________________
`
`
`JANSSEN ONCOLOGY, INC.’S UPDATED MANDATORY NOTICES
`
`
`1 Case IPR2016-01317 has been joined with this proceeding.
`
`
`
`
`
`
`
`IPR2016-00286
`U.S. Patent 8,822,438
`
`
`Janssen Oncology, Inc. submits the following updated mandatory disclosures
`
`pursuant to 37 C.F.R. §42.8. Specifically, Janssen Oncology, Inc. is updating its
`
`backup counsel.
`
`REAL PARTY-IN-INTEREST
`
`Janssen Oncology, Inc., a wholly-owned subsidiary of Johnson & Johnson
`
`(“J&J”), is a real party-in-interest. J&J, a publicly held company, is also a real
`
`party-in-interest.
`
`RELATED MATTERS
`
`U.S. Patent 8,822,438 (the “’438 Patent”) issued from U.S. Application No.
`
`13/034,340 (the “’340 Application”). U.S. Patent Application No. 14/750,297,
`
`which is currently pending before the Office, claims the benefit of the ’340
`
`Application.
`
`The ’438 Patent is being asserted in the following patent infringement
`
`lawsuits:
`
` BTG International Limited, et al. v. Actavis Laboratories FL, Inc., et
`
`al., C.A. No. 2:15-cv-05909-KM-JBC (D.N.J.);
`
` Janssen Biotech, Inc., et al. v. Mylan Pharmaceuticals Inc., et al.,
`
`C.A. No. 1:15-cv-00130-IMK (N.D. W. Va.);
`
` BTG International Limited, et al. v. Amerigen Pharmaceuticals, Inc. et
`
`al., C.A. No. 2:16-cv-02449-KM-JBC (D.N.J.); and
`
`1
`
`
`
`
`
`IPR2016-00286
`U.S. Patent 8,822,438
`
`
` BTG International Limited, et al. v. Glenmark Pharmaceuticals Inc.,
`
`USA et al., C.A. No. 2:16-cv-03743-KM-JBC (D.N.J).
`
`The ’438 Patent was asserted in the following patent infringement lawsuits
`
`that have now been terminated:
`
` Janssen Biotech, Inc., et al. v. Par Pharmaceutical, Inc., et al., C.A.
`
`No. 1:15-cv-00679-SLR (D. Del.); and
`
` BTG International Limited, et al. v. Actavis Laboratories FL, Inc., et
`
`al., C.A. No. 9:15-cv-81076-DMM (S.D. Fla.).
`
`
`LEAD AND BACKUP COUNSEL
`
`Lead Counsel
`
`
`Dianne B. Elderkin
`AKIN GUMP STRAUSS HAUER
`& FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1340
`Fax: (215) 965-1210
`delderkin@akingump.com
`USPTO Registration No. 28,598
`
`Backup Counsel
`
`
`
`
`Barbara L. Mullin
`AKIN GUMP STRAUSS HAUER
`& FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1243
`Fax: (215) 965-1210
`bmullin@akingump.com
`USPTO Registration No. 38,250
`
`
`
`2
`
`
`
`IPR2016-00286
`U.S. Patent 8,822,438
`
`Lead Counsel
`
`
`
`
`
`
`
`
`
`
`Backup Counsel
`
`
`Ruben H. Munoz
`AKIN GUMP STRAUSS HAUER
`& FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1263
`Fax: (215) 965-1210
`rmunoz@akingump.com
`USPTO Registration No. 66,998
`
`Todd L. Krause
`SIDLEY AUSTIN LLP
`787 Seventh Avenue
`New York, NY 10019
`Tel.: (212) 839-5696
`Fax: (212) 839-5599
`tkrause@sidley.com
`USPTO Registration No. 48,860
`
`Bindu Donovan
`SIDLEY AUSTIN LLP
`787 Seventh Avenue
`New York, NY 10019
`Tel.: (212) 839-8742
`Fax: (212) 839-5599
`bdonovan@sidley.com
`Admitted pro hac vice
`
`
`3
`
`
`
`IPR2016-00286
`U.S. Patent 8,822,438
`
`Lead Counsel
`
`
`
`
`
`
`
`
`
`
`
`Backup Counsel
`
`David T. Pritikin
`SIDLEY AUSTIN LLP
`One South Dearborn
`Chicago, IL 60603
`Tel.: (312) 853-7359
`Fax: (312) 853-7036
`dpritikin@sidley.com
`Admitted pro hac vice
`
`S. Isaac Olson
`SIDLEY AUSTIN LLP
`787 Seventh Avenue
`New York, NY 10019
`Tel.: (212) 839-6756
`Fax: (212) 839-5599
`iolson@sidley.com
`Admitted pro hac vice
`
`Alyssa B. Monsen
`SIDLEY AUSTIN LLP
`787 Seventh Avenue
`New York, NY 10019
`Tel.: (212) 839-5346
`Fax: (212) 839-5599
`amonsen@sidley.com
`Admitted pro hac vice
`
`Paul J. Zegger
`SIDLEY AUSTIN LLP
`1501 K Street, N.W.
`Washington, DC 20005
`Tel.:(202) 736-8060
`Fax: (202) 736-8711
`pzegger@sidley.com
`USPTO Registration No. 33,821
`
`
`4
`
`
`
`IPR2016-00286
`U.S. Patent 8,822,438
`
`Lead Counsel
`
`
`
`
`
`
`
`
`
`
`
`Backup Counsel
`
`Anthony C. Tridico
`FINNEGAN HENDERSON
`FARABOW GARRETT & DUNNER
`16 Old Bailey
`London EC4M 7EG
`United Kingdom
`Tel.: +44 (0)20 7864 2800
`anthony.tridico@finnegan.com
`USPTO Registration No. 45,958
`
`Jennifer H. Roscetti
`FINNEGAN HENDERSON
`FARABOW GARRETT & DUNNER
`901 New York Ave NW
`Washington, D.C. 20001
`Tel.: (202) 408-4150
`Fax: (202) 408-4400
`jennifer.roscetti@finnegan.com
`USPTO Registration No. 71,998
`
`SERVICE INFORMATION
`
`Janssen consents to electronic service at the following email address:
`
`JANS-ZYTIGA@akingump.com
`ZytigaIPRTeam@sidley.com
`
`Janssen may be served by postal mailing or hand-delivery as follows:
`
`Dianne B. Elderkin
`AKIN GUMP STRAUSS HAUER & FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1340
`Fax: (215) 965-1210
`
`5
`
`
`
`IPR2016-00286
`U.S. Patent 8,822,438
`
`
`Date: January 4, 2017
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`
`
`6
`
`
`
`
`
`
`
`IPR2016-00286
`U.S. Patent 8,822,438
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Janssen
`
`Oncology, Inc.’s Updated Mandatory Notices was served on counsel of record on
`
`January 4, 2017 by filing this document through the End-to-End System, as well as
`
`delivering a copy via electronic mail to counsel of record for the Petitioner and
`
`Patent Co-Owner at the following addresses:
`
`William Hare - bill@miplaw.com
`Gabriela Materassi - materassi@miplaw.com
`
`Teresa Stanek Rea - TRea@Crowell.com
`Shannon M. Lentz - SLentz@Crowell.com
`
`Anthony C. Tridico - anthony.tridico@finnegan.com
`Jennifer H. Roscetti - jennifer.roscetti@finnegan.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`By: /Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`7
`
`
`
`Date: January 4, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`